BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 21307850)

  • 1. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
    Yazawa M; Hsueh B; Jia X; Pasca AM; Bernstein JA; Hallmayer J; Dolmetsch RE
    Nature; 2011 Mar; 471(7337):230-4. PubMed ID: 21307850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Timothy syndrome with iPS cells.
    Yazawa M; Dolmetsch RE
    J Cardiovasc Transl Res; 2013 Feb; 6(1):1-9. PubMed ID: 23299782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome.
    Song L; Park SE; Isseroff Y; Morikawa K; Yazawa M
    Stem Cell Reports; 2017 Jul; 9(1):50-57. PubMed ID: 28648896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the long QT syndrome with induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
    Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8).
    Drum BM; Dixon RE; Yuan C; Cheng EP; Santana LF
    J Mol Cell Cardiol; 2014 Jan; 66():63-71. PubMed ID: 24215710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.
    Song L; Awari DW; Han EY; Uche-Anya E; Park SH; Yabe YA; Chung WK; Yazawa M
    Stem Cells Transl Med; 2015 May; 4(5):468-75. PubMed ID: 25769651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.
    Limpitikul WB; Dick IE; Joshi-Mukherjee R; Overgaard MT; George AL; Yue DT
    J Mol Cell Cardiol; 2014 Sep; 74():115-24. PubMed ID: 24816216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome.
    Paşca SP; Portmann T; Voineagu I; Yazawa M; Shcheglovitov A; Paşca AM; Cord B; Palmer TD; Chikahisa S; Nishino S; Bernstein JA; Hallmayer J; Geschwind DH; Dolmetsch RE
    Nat Med; 2011 Nov; 17(12):1657-62. PubMed ID: 22120178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein.
    Cheng EP; Yuan C; Navedo MF; Dixon RE; Nieves-Cintrón M; Scott JD; Santana LF
    Circ Res; 2011 Jul; 109(3):255-61. PubMed ID: 21700933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca(2+)-dependent inactivation.
    Dick IE; Joshi-Mukherjee R; Yang W; Yue DT
    Nat Commun; 2016 Jan; 7():10370. PubMed ID: 26822303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timothy syndrome iPSC modeling.
    Bekdash R; Klein AD; Yazawa M
    Mol Cell Neurosci; 2020 Sep; 107():103529. PubMed ID: 32629111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timothy syndrome-like condition with syndactyly but without prolongation of the QT interval.
    Kosaki R; Ono H; Terashima H; Kosaki K
    Am J Med Genet A; 2018 Jul; 176(7):1657-1661. PubMed ID: 29736926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
    Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
    J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside.
    Han D; Xue X; Yan Y; Li G
    Exp Biol Med (Maywood); 2019 Sep; 244(12):960-971. PubMed ID: 31324123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-type Ca2+ channel function during Timothy syndrome.
    Dixon RE; Cheng EP; Mercado JL; Santana LF
    Trends Cardiovasc Med; 2012 Apr; 22(3):72-6. PubMed ID: 22999068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
    De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
    Wemhöner K; Friedrich C; Stallmeyer B; Coffey AJ; Grace A; Zumhagen S; Seebohm G; Ortiz-Bonnin B; Rinné S; Sachse FB; Schulze-Bahr E; Decher N
    J Mol Cell Cardiol; 2015 Mar; 80():186-95. PubMed ID: 25633834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.